BNP Paribas Financial Markets
OLMA icon

BNP Paribas Financial Markets’s Olema Pharmaceuticals OLMA Stock Holding History

BNP Paribas Financial Markets’s Portfolio OLMA Stock Details OLMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$160K Sell
12,760
-8,910
-41% -$119K ﹤0.01% 4332
2026
Q1 		$323K Buy
21,670
+11,308
+109% +$252K ﹤0.01% 3824
2025
Q4 		$259K Sell
10,362
-289,257
-97% -$5.15M ﹤0.01% 3936
2025
Q3 		$2.93M Buy
299,619
+293,034
+4,450% +$1.76M ﹤0.01% 2337
2025
Q2 		$28.1K Sell
6,585
-361,519
-98% -$1.61M ﹤0.01% 4468
2025
Q1 		$1.38M Buy
368,104
+174,356
+90% +$877K ﹤0.01% 2564
2024
Q4 		$1.13M Buy
+193,748
New +$1.94M ﹤0.01% 2735

Other funds holding OLMA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return

BNP Paribas Financial Markets's OLMA Position: Q2 2026 in Review

BNP Paribas Financial Markets reduced its Olema Pharmaceuticals (OLMA) stake by 41% in Q2 2026, selling an estimated $119K and leaving 12,760 shares worth $160K. The position accounts for ﹤0.01% of the portfolio, ranked #4332.

BNP Paribas Financial Markets first reported a position in OLMA in Q4 2024 and has held it in 7 quarters since. The position peaked at $2.93M in Q3 2025. 185 funds tracked by Wall St. Rank hold OLMA as of Q2 2026.

  • BNP Paribas Financial Markets held 12,760 shares of Olema Pharmaceuticals worth $160K as of Q2 2026.
  • BNP Paribas Financial Markets sold 8,910 Olema Pharmaceuticals shares in Q2 2026, an estimated $119K.
  • Olema Pharmaceuticals made up ﹤0.01% of BNP Paribas Financial Markets's portfolio in Q2 2026, its #4332 holding.
  • BNP Paribas Financial Markets first reported a position in Olema Pharmaceuticals in Q4 2024 and has held it in 7 quarters since.
  • BNP Paribas Financial Markets's Olema Pharmaceuticals position peaked at $2.93M in Q3 2025.
  • 185 funds tracked by Wall St. Rank held Olema Pharmaceuticals as of Q2 2026.

Based on BNP Paribas Financial Markets's 13F filing for Q2 2026, filed 13 Aug 2026.